A Phase 2 study of S-237648 in Japanese obese patients with impaired glucose tolerance/type 2 diabetes mellitus and hyperlipidemia
Phase of Trial: Phase II
Latest Information Update: 28 Dec 2016
At a glance
- Drugs S 237648 (Primary)
- Indications Obesity
- Focus Therapeutic Use
- Sponsors Shionogi
- 27 Dec 2016 Status changed from active, no longer recruiting to completed.
- 15 Sep 2016 Status changed from recruiting to active, no longer recruiting.
- 09 Jun 2016 New trial record